For the Inventor, By the Inventor

Enter inventor name

Bridgewater, NJ, United States of America

Dominick Anthony Quagliato

USPTO Granted Patents = 22 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 143(Granted Patents)

Location History:

North Brunswick, NJ (US) (1990)
No. Brunswick, NJ (US) (1991)
Edison, NJ (US) (1991 - 1993)
Bridgewater, NJ (US) (1998 - 2010)

Company Filing History:

13 out of 1,309

American Home Products Corporation

Years Active: 1990-2010

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7705030 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation (2010-04-27),

2. 7691848 - Pyrrolobenzodiazepine arylcarboxamides and derivatives thereof as follicle-stimulating hormone receptor antagonists (2010-04-06),

3. 7687623 - Pyrrolobenzodiazepines and heterocyclic carboxamide derivatives as follicle stimulating hormone receptor (FSH-R) antagonists (2010-03-30),

4. 7678787 - Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists (2010-03-16),

5. 7666904 - 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof (2010-02-23),

6. 7582667 - Dihydrospiro[dibenzo[a,d][7]annulene-5,4'-imidazol] compounds for the inhibition of beta-secretase (2009-09-01),

7. 7495027 - 3-aryl-4-hydroxyfuranone compounds and the human and animal health use thereof (2009-02-24),

8. 7452885 - Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation (2008-11-18),

9. 7423158 - Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds for the inhibition of β-secretase (2008-09-09),

10. 7417047 - Amino-5-(5-membered)hetero-arylimidazolone compounds and the use thereof for β-secretase modulation (2008-08-26),

11. 6605618 - Heterocyclic beta-3 adrenergic receptor agonists (2003-08-12),

12. 6458817 - Substituted arylsulfides, arylsulfoxides and arylsulfones as beta-3 adrenergic receptor agonists (2002-10-01),

13. 6451814 - Heterocyclic &bgr;-3 adrenergic receptor agonists (2002-09-17),

14. 5840764 - Substituted hydroxy-anilino derivatives of cyclobutene-3,4-diones (1998-11-24),

15. 5780505 - Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones (1998-07-14),

Title: The Innovative Mind of Dominick Anthony Quagliato

Introduction:

Dominick Anthony Quagliato, a talented inventor hailing from Bridgewater, NJ, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents:

Quagliato's latest patents showcase his ingenuity and forward-thinking approach to problem-solving in various industries, including telecommunications, renewable energy, and healthcare.

Career Highlights:

Throughout his illustrious career, Dominick Anthony Quagliato has been recognized for his exceptional creativity and technical expertise. His inventions have revolutionized the way we interact with technology on a daily basis.

Collaborations:

Quagliato has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life. His partnerships have led to the development of cutting-edge technologies that have had a lasting impact on society.

Conclusion:

In conclusion, Dominick Anthony Quagliato's passion for innovation and dedication to pushing the boundaries of what is possible have solidified his reputation as a pioneering inventor in the world of technology. His work continues to inspire future generations of inventors to think outside the box and pursue their creative visions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…